Complete Up To Date Information about Adequan Injectable.
NADA Number: 136-383 | |
| Proprietary Name |
Adequan® Injectable |
|---|---|
| Sponsor |
Luitpold Pharmaceuticals, Inc. |
| Ingredients |
Polysulfated Glycosaminoglycan |
| Species |
Horse, not for meat production |
| Routes of Administration |
Intra-articular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.1850 Polysulfated glycosaminoglycan. Specifications: Each 1-milliliter ampule of sterile aqueous solution contains 250 milligrams of polysulfated glycosaminoglycan. Conditions of use: Horses Amount: 250 milligrams intra-articular use once a week for 5 weeks. The joint area must be shaved, cleaned, and sterilized as in a surgical procedure prior to injection. If the joint reacts with excessive inflammation, after intra-articular treatment, cease therapy. Indications: Polysulfated glycosaminoglycan is for the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses. Limitations: Not for use in horses intended for food. Safe use in breeding animals has not been established. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |